This inventor holds 3 USPTO granted patents and 1 EPO patent. Top assignee: University of California. Active years: 2017-2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017-2021
Title: Innovations by Noel Youngho Jee
Introduction
Noel Youngho Jee is an accomplished inventor based in San Francisco, CA. He has made significant contributions to the field of cellular biology, holding a total of 3 patents. His work focuses on innovative methods and compositions that enhance cellular adhesion and tissue engineering.
Latest Patents
One of his latest patents involves the reprogramming of cellular adhesion. This patent discloses membrane-anchored polynucleotides and compositions that include these polynucleotides. The patent also outlines processes for synthesizing these compounds, as well as their applications in research and therapeutic settings. Another notable patent details methods for patterning cells on a substrate surface. This method includes disposing a pattern of nucleic acids on a substrate and using a first suspension of cells that contain cell surface-attached nucleic acids complementary to the patterned nucleic acids. This innovative approach allows for the precise patterning of cells, which is crucial for developing three-dimensional living tissues.
Career Highlights
Noel Youngho Jee is affiliated with the University of California, where he continues to advance his research and innovations. His work has garnered attention for its potential applications in regenerative medicine and tissue engineering.
Collaborations
He collaborates with notable colleagues, including Zev Jordan Gartner and Michael E Todhunter, who contribute to his research endeavors.
Conclusion
Noel Youngho Jee's innovative patents and research at the University of California highlight his significant contributions to cellular biology and tissue engineering. His work continues to pave the way for advancements in therapeutic applications and regenerative medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
